Respiratory Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1464 | Report Format : | Status : Upcoming |

Abstract

Global Respiratory Diagnostics Market: Overview

People from every corner of the world may have suffered from some kind of respiratory diseases. Respiratory diseases may result in death if they are not properly diagnosed. Commonly prevalent respiratory diseases include asthma, acute respiratory infections, chronic obstructive pulmonary disease, and others. In the respiratory diagnostics, radiographic procedures hold a very important place. Respiratory diagnostics highlight the greatest concern of the respiratory diseases and provide remedies to combat against threats of these diseases.

Global Respiratory Diagnostics Market: Growth Factors

The major factors driving the market growth are the rise in the cases of respiratory diseases, increasing aging population, and technological advancement. Increasing government support for R&D and development in the healthcare sector are factors that anticipate fueling the market growth. Well-established hospitals and clinics with advanced medical equipment also contribute to the rise of the global respiratory diagnostics market. Increasing population and changing climate are influencing the market in a positive way. However, a presence of large population going undiagnosed and undertreated, lack of awareness, and increasing concerns regarding healthcare costs are factors that restrain the market growth.

Global Respiratory Diagnostics Market: Segmentation

The global respiratory diagnostics market is classified based on the end-user which includes clinical laboratories, physician offices, reference laboratories, and others. Based on test type, the global market is fragmented into imaging tests, traditional diagnostic tests, molecular diagnostic tests, and mechanical tests. The traditional diagnostic tests segment is dominating the global market owing to the quick turnaround time of these tests. The disease segment is classified as tuberculosis, chronic obstructive pulmonary disease, asthma, lung cancer, and other diseases. The tuberculosis disease segment contributed the largest market share due to increasing use of tobacco smoking and increasing air pollution. Based on product and service, the global respiratory diagnostics market is segregated into services and software, instruments and devices, and assays and reagents.

Global Respiratory Diagnostics Market: Regional Analysis

North America has generated a large demand for respiratory diagnostics across the world owing to rapid growth in the geriatric population and rising prevalence of respiratory diseases. Europe is another potential market that is growing at a fast rate due to the presence of developed healthcare system. In addition, availability of the good distribution channels for respiratory diagnostic products in this region is expected to propel the global respiratory diagnostics market growth. Other developing countries such as Australia, South Korea, China, Taiwan, and India are witnessing lucrative growth opportunities. Increasing investments in the healthcare industry, growth in geriatric population, and growing per capita income are key factors responsible for the market growth in Asia-Pacific region. Expansion of private-sector hospitals in rural areas is also a factor that has contributed to the market growth in this region.

Global Respiratory Diagnostics Market: Competitive Players

Major vendors of global respiratory diagnostics market include Thermo Fisher Scientific Inc., Philips Healthcare, Seegene Inc., Abbott Laboratories, Biomérieux, and Becton, Dickinson & Company. Other influencing players include SDD Diagnostics, Bio-Rad Laboratories, Inc., Cosmed, and Alere Inc.

Global Respiratory Diagnostics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Jan-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2534 | Report Format:

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy mar...Read More

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2525 | Report Format:

Global Compounding Pharmacies Market: Overview Compounding is the knowledge of preparing and combining tailored medicines for users. These medicines are made on the basis of the prescription from the practitioner wherein, the separate ingredients are blended together according to the recommended...Read More

Antithrombin Market by (Source- Human, and Goat Milk; Application - Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2514 | Report Format:

The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the imp...Read More

Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine and Combined Drug), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Sales), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2513 | Report Format:

The report covers forecast and analysis for the Alzheimers drugs market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the Alzheimers drugs market along ...Read More

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2512 | Report Format:

The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive p...Read More

Choose License Type:
Latest Published Reports

View All Published Reports